Article
Disruptive Technology: CRISPR/Cas-Based Tools and Approaches
1 Apr 2019
Abstract excerpt
Designer nucleases are versatile tools for genome modification and therapy development and have gained widespread accessibility with the advent of clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein (Cas) technology. Prokaryotic RNA-guided nucleases of CRISPR/Cas type, since first being adopted as editing tools in eukaryotic cells, have experienced rapid uptake and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
